dc.creatorSaid, Juan Carlos
dc.creatorLetelier, Luz María
dc.creatorGonzález, Alejandro
dc.creatorEscobillana, Cristóbal
dc.creatorPisano, Raúl
dc.date.accessioned2019-03-15T16:04:17Z
dc.date.available2019-03-15T16:04:17Z
dc.date.created2019-03-15T16:04:17Z
dc.date.issued2012
dc.identifierRevista Medica de Chile, Volumen 140, Issue 10, 2018, Pages 1342-1346
dc.identifier00349887
dc.identifier07176163
dc.identifier10.4067/S0034-98872012001000016
dc.identifierhttps://repositorio.uchile.cl/handle/2250/165929
dc.description.abstractCollapsing glomerulopathy is a cause of nephrotic syndrome with massive proteinuria secondary to podocyte proliferation and glomerular collapse. It is characterized by an almost inevitable progression to end stage renal failure, poor response to treatment and high post-transplant recurrence. Its frequency has increased in recent years due to its common association with Human Immunodeficiency Virus (HIV) infection and the growing recognition of new etiologic agents such as drugs and parvovirus B19. Therefore, it is a disease of growing interest for clinicians. The aim of this review is to update the clinical presentation, diagnosis, pathogenesis and therapeutic alternatives of this disease.
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceRevista Medica de Chile
dc.subjectGlomerulopathies
dc.subjectHIV
dc.subjectParvovirus
dc.titleCollapsing glomerulopathy Glomerulopatía colapsante
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución